Swiss (SMI) Biotech Industry Analysis
UpdatedJun 07, 2023
DataAggregated Company Financials
Companies7
- 7D2.0%
- 3M-21.0%
- 1Y-59.6%
- YTD-25.7%
Over the last 7 days, the Biotech industry has risen 2.0%, driven by gains from Idorsia of 7.2%. In contrast, the industry has lost 60% in the last 12 months. Earnings are forecast to grow by 9.3% annually.
Industry Valuation and Performance
Has the Swiss Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 07 Jun 2023 | CHF325.2m | CHF334.1m | -CHF181,188,533.00 | n/a | -1.8x | 1x |
| Fri, 05 May 2023 | CHF381.0m | CHF496.3m | -CHF18,252,374.00 | 1.7x | -20.9x | 0.8x |
| Sun, 02 Apr 2023 | CHF428.2m | CHF497.3m | CHF12.3m | 1.5x | 34.8x | 0.9x |
| Tue, 28 Feb 2023 | CHF490.4m | CHF493.4m | CHF14.5m | 1.6x | 33.8x | 1x |
| Thu, 26 Jan 2023 | CHF511.5m | CHF493.4m | CHF14.5m | 1.7x | 35.3x | 1x |
| Sat, 24 Dec 2022 | CHF501.6m | CHF493.4m | CHF14.5m | 1.7x | 34.6x | 1x |
| Mon, 21 Nov 2022 | CHF515.5m | CHF494.8m | CHF14.5m | 1.8x | 35.6x | 1x |
| Wed, 19 Oct 2022 | CHF509.7m | CHF510.1m | CHF15.9m | 1.9x | 32.1x | 1x |
| Fri, 16 Sep 2022 | CHF529.0m | CHF495.8m | CHF27.8m | 1.9x | 19x | 1.1x |
| Sun, 14 Aug 2022 | CHF527.5m | CHF482.7m | CHF38.7m | 1.9x | 13.6x | 1.1x |
| Tue, 12 Jul 2022 | CHF585.5m | CHF460.6m | CHF81.6m | 2.2x | 7.2x | 1.3x |
| Thu, 09 Jun 2022 | CHF626.5m | CHF470.6m | CHF25.0m | 2.1x | 25x | 1.3x |
| Sat, 07 May 2022 | CHF721.2m | CHF301.5m | -CHF144,267,932.00 | 1.9x | -5x | 2.4x |
| Mon, 04 Apr 2022 | CHF1.2b | CHF288.4m | -CHF143,186,966.00 | 2x | -8.2x | 4.1x |
| Wed, 02 Mar 2022 | CHF1.3b | CHF281.4m | -CHF139,079,671.00 | 2x | -9.5x | 4.7x |
| Fri, 28 Jan 2022 | CHF5.2b | CHF320.6m | -CHF658,577,634.00 | 1.5x | -7.9x | 16.3x |
| Sun, 26 Dec 2021 | CHF4.2b | CHF317.4m | -CHF659,020,639.00 | 1.5x | -6.3x | 13.2x |
| Tue, 23 Nov 2021 | CHF3.8b | CHF320.3m | -CHF658,611,195.00 | 1.5x | -5.7x | 11.8x |
| Thu, 21 Oct 2021 | CHF4.7b | CHF304.9m | -CHF641,744,123.00 | 2.3x | -7.3x | 15.3x |
| Sat, 18 Sep 2021 | CHF5.3b | CHF302.6m | -CHF612,743,058.00 | 1.3x | -8.6x | 17.4x |
| Mon, 16 Aug 2021 | CHF5.4b | CHF306.0m | -CHF612,309,374.80 | 1.1x | -8.8x | 17.6x |
| Mon, 31 May 2021 | CHF5.8b | CHF352.3m | -CHF535,605,963.80 | 1.1x | -10.8x | 16.4x |
| Thu, 04 Mar 2021 | CHF6.2b | CHF407.2m | -CHF561,055,198.50 | 6x | -11.1x | 15.3x |
| Sun, 06 Dec 2020 | CHF6.5b | CHF399.6m | -CHF565,530,866.50 | 7.1x | -11.5x | 16.3x |
| Wed, 09 Sep 2020 | CHF6.0b | CHF393.6m | -CHF565,357,804.50 | 496.9x | -10.6x | 15.2x |
Price to Earnings Ratio
-8.7x
Current Industry PE
- Investors are pessimistic on the Swiss Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 9.2x is higher than the industry's current PS ratio of 0.97x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 5.3% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare industry?
| CH Market | 1.21% | |
| Healthcare | 2.60% | |
| Biotech | 1.98% | |
| Biotech | 1.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IDIA Idorsia | CHF8.24 | 7.2% +CHF97.9m | -45.7% | PS13x | |
| MOLN Molecular Partners | CHF6.10 | 6.5% +CHF12.1m | -14.1% | PS10.1x | |
| SANN Santhera Pharmaceuticals Holding | CHF0.92 | 12.7% +CHF12.0m | -12.2% | PS14.3x | |
| KURN Kuros Biosciences | CHF1.38 | 3.4% +CHF1.6m | -29.1% | PS2.8x | |
| SPEX Spexis | CHF0.35 | 0.6% +CHF1.1m | -66.5% | PS12.5x |